Does delay of adjuvant chemotherapy impact survival in patients with resected stage ii and iii colon adenocarcinoma?

Cancer

Volumn 117, Issue 11, 2011, Pages 2364-2370

  Bayraktar, Ulas Darda ^a   Chen, Emerson ^b   Bayraktar, Soley ^a   Sands, Laurence R ^a   Marchetti, Floriano ^a   Montero, Alberto Jose ^a   Rocha Lima, Caio Max S ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

5 fluorouracil; Adjuvant chemotherapy; Cancer therapy delay; Colon cancer; Disparity; Oxaliplatin

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COLON ADENOCARCINOMA; COLON RESECTION; CONTROLLED STUDY; EARLY INTERVENTION; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT REFERRAL; PRIORITY JOURNAL; RELAPSE FREE SURVIVAL; SURGICAL INFECTION; SURVIVAL; THERAPY DELAY; WOUND DEHISCENCE;

5-FLUOROURACIL; ADJUVANT CHEMOTHERAPY; CANCER THERAPY DELAY; COLON CANCER; DISPARITY; OXALIPLATIN;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; TIME FACTORS;

EID: 79958049939     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25720     Document Type: Article

References (28)

1. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-358. (Pubitemid 20042739)
2. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol. 1993;11:1879-1887. (Pubitemid 23304611)
3. O'Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol. 1997;15:246-250. (Pubitemid 27020580)
4. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-2351. (Pubitemid 38702845)
5. Wolmark N, Wieand, S, Kuebler, PJ. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: survival results of NSABP Protocol C-07. J Clin Oncol. 2008;26:1008s.
6. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005;352:2696-2704. (Pubitemid 41007824)
7. Benson AB III, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004; 22:3408-3419. (Pubitemid 41103700)
8. Baum M, Demicheli R, Hrushesky W, Retsky M. Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005;41:508-515. (Pubitemid 40292730)
9. Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 1989;49:1996-2001. (Pubitemid 19106503)
10. Hensler T, Hecker H, Heeg K, et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun. 1997;65:2283-2291. (Pubitemid 27237311)
11. Harless W, Qiu Y. Cancer: a medical emergency. Med Hypotheses. 2006;67:1054-1059. (Pubitemid 44302239)
12. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989;7:1447-1456. (Pubitemid 19245114)
13. Taal BG, Van Tinteren H, Zoetmulder FA. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer. 2001;85:1437-1443. (Pubitemid 34001570)
14. O'Connell MJ, Laurie JA, Kahn M, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol. 1998; 16:295-300. (Pubitemid 28041612)
15. Moertel CG, Fleming TR, Macdonald JS, et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol. 1995;13: 2936-2943.
16. Andre T, Colin P, Louvet C, et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol. 2003;21:2896-2903. (Pubitemid 46621839)
17. Arkenau HT, Bermann A, Rettig K, Strohmeyer G, Porschen R. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol. 2003;14:395-399. (Pubitemid 36367416)
18. Glimelius B, Dahl O, Cedermark B, et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol. 2005;44:904-912. (Pubitemid 41780118)
19. Berglund A, Cedermark B, Glimelius B. Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III? Ann Oncol. 2008;19:400-402. (Pubitemid 351201732)
20. Chau I, Norman AR, Cunningham D, et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol. 2005; 16:549-557. (Pubitemid 40613320)
21. Biagi JJ, Barnes C, O'Callaghan CJ. Time to adjuvant chemotherapy in colorectal cancer. Paper presented at: 2007 Gastrointestinal Cancers Symposium, Orlando, FL, January 19, 2001.
22. Czaykowski P, Gill S, Kennecke H, Turner D, Gordon V. Adjuvant chemotherapy (AC) for stage 3 colon cancer: does timing matter? Paper presented at: 2007 Gastrointestinal Cancers Symposium, Orlando, FL, January 19, 2001.
23. Ahmad I, Anan G, Alvi R. Impact of timing of initiation of adjuvant chemotherapy on survival after resection of colorectal cancer. J Clin Oncol. 2007;25(18 suppl):4054.
24. Carlsson G, Albertsson P, Gustavsson B. Delayed start of adjuvant 5-FU/leucovorin based chemotherapy in colon cancer is safe up to 12 weeks postoperatively. J Clin Oncol. 2007;25(18 suppl):4056.
25. Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107:2581-2588. (Pubitemid 44845611)
26. Adam SA, Horner JK, Vessey MP. Delay in treatment for breast cancer. Community Med. 1980;2:195-201. (Pubitemid 11233629)
27. Kim J, Mittal R, Konyalian V, King J, Stamos MJ, Kumar RR. Outcome analysis of patients undergoing colorectal resection for emergent and elective indications. Am Surg. 2007;73:991-993. (Pubitemid 351396551)
28. Langenbach MR, Schmidt J, Neumann J, Zirngibl H. Delay in treatment of colorectal cancer: multifactorial problem. World J Surg. 2003;27:304-308. (Pubitemid 36920142)